Search results (282)
« Back to PublicationsDiagnostic criteria for invasive pulmonary aspergillosis in COPD patients
Journal article
Denning DW. et al, (2026), American Journal of Respiratory and Critical Care Medicine
Using Historical Blood Eosinophil Counts to Guide Treatment Decisions in Patients With Chronic Obstructive Pulmonary Disease
Journal article
Bafadhel M. et al, (2026), CHEST
Eosinophil biology in COPD; from scientific insight to clinical treatment action
Journal article
Cass SP. and Bafadhel M., (2026), ERJ Open Research, 01301 - 2025
Longitudinal changes in cardiopulmonary outcomes of adults born extremely prematurely: United Kingdom Oscillation Study
Journal article
Jenkinson A. et al, (2026), Pediatric Research, 99, 106 - 111
Respiratory Clinicians’ Views on Offering “Rescue Packs” to Patients Discharged After COPD Exacerbation: Qualitative Interview Study
Journal article
Kuberska K. et al, (2025), COPD: Journal of Chronic Obstructive Pulmonary Disease, 22
Rebranding COPD Care and Research in the 21st Century
Journal article
Soriano JB. et al, (2025), Respirology, 30, 1025 - 1028
Fractional exhaled nitric oxide and the response to prednisolone for asthma attacks in patients treated with anti-IL5/5Rα therapy: a prospective observational study
Journal article
Howell I. et al, (2025), European Respiratory Journal, 66, 2501229 - 2501229
The Risk–Benefit Balance of Oral Corticosteroid Treatment for Asthma Attacks: A Discrete Choice Experiment of Patients and Healthcare Professionals in the UK and New Zealand
Journal article
Howell I. et al, (2025), Respirology, 30, 1035 - 1045
Effect of budesonide/glycopyrronium/formoterol fumarate dihydrate on cardiopulmonary outcomes in COPD: rationale and design of the THARROS trial
Journal article
Martinez FJ. et al, (2025), ERJ Open Research, 11, 00324 - 2025
A translational view of airway epithelial dysfunction in COPD
Journal article
Brightling CE. et al, (2025), European Respiratory Review, 34, 250110 - 250110
Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial
Journal article
Christenson SA. et al, (2025), The Lancet Respiratory Medicine, 13, 687 - 697
Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β2-agonist: post-hoc analyses of KRONOS
Journal article
Singh D. et al, (2025), Respiratory Research, 26
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores
Journal article
Vogelmeier CF. et al, (2025), Respiratory Medicine, 241, 108015 - 108015
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
Journal article
Sciurba FC. et al, (2025), New England Journal of Medicine, 392, 1710 - 1720
Inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review and meta-analysis on mortality protection - making a long story short
Journal article
Rogliani P. et al, (2025), Expert Review of Respiratory Medicine, 19, 245 - 255